Skip to content

Released Feb 8, 2024, after the close

10-Q filed Feb 8, 2024, 39 days after period end · 0001516513-24-000009

Q3 2024 · 10-Q
Revenue$135.28M+17.4% vs Q3 2023+19.1% vs Q2 2024
Net Income$47.96M+43.3% vs Q3 2023+56.7% vs Q2 2024
EPS Diluted$0.24+50.0% vs Q3 2023+60.0% vs Q2 2024
Gross Profit$123,094,000+21.0%
Operating Income$58,551,000+52.1%
Operating Cash Flowderived$50,054,000+2.8%
Free Cash Flowderived$50,018,000+3.1%
Margins · derived
Gross margin91.0%+2.7 pt vs Q3 2023
Operating margin43.3%+9.9 pt vs Q3 2023
Net margin35.4%+6.4 pt vs Q3 2023

What the release said

The release

Same quarter

MetricQ3 2024Q3 2023Q3 2022Q3 2021
Revenue$135.28M$115.26M$97.88M$58.71M
Net Income$47.96M$33.47M$55.65M$17.23M
EPS Diluted$0.24$0.16$0.26$0.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Doximity, Inc. · CIK 1516513 · Engraved from SEC EDGAR